Healthcare -
Biotechnology - NASDAQ - US
$ 0.6504
-15 %
$ 146 M
Market Cap
-1.25
P/E
SGMO - REVENUE
Revenue SGMO - Sangamo Therapeutics, Inc.
57.8 M
LAST VALUE
-27.94%
2 YEAR CAGR
-10.81%
5 YEAR CAGR
2.34%
10 YEAR CAGR